Janus Henderson Group PLC Raises Stock Holdings in Oscar Health, Inc. (NYSE:OSCR)

Janus Henderson Group PLC raised its holdings in shares of Oscar Health, Inc. (NYSE:OSCR) by 27.1% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 72,236 shares of the company’s stock after purchasing an additional 15,400 shares during the quarter. Janus Henderson Group PLC’s holdings in Oscar Health were worth $1,532,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Raymond James & Associates bought a new stake in shares of Oscar Health in the second quarter worth $3,168,000. Hennessy Advisors Inc. acquired a new position in Oscar Health during the 2nd quarter worth $9,047,000. Catalyst Capital Advisors LLC bought a new stake in shares of Oscar Health in the 2nd quarter worth about $1,535,000. Bank of New York Mellon Corp raised its stake in shares of Oscar Health by 161.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 1,393,048 shares of the company’s stock valued at $22,038,000 after purchasing an additional 860,226 shares in the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank lifted its position in shares of Oscar Health by 26.9% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 24,210 shares of the company’s stock worth $383,000 after purchasing an additional 5,138 shares during the last quarter. 75.70% of the stock is currently owned by hedge funds and other institutional investors.

Oscar Health Stock Up 0.1 %

Oscar Health stock opened at $13.66 on Friday. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.73 and a current ratio of 0.73. Oscar Health, Inc. has a one year low of $7.67 and a one year high of $23.79. The company has a 50-day simple moving average of $16.33 and a 200-day simple moving average of $17.64. The firm has a market capitalization of $3.38 billion, a P/E ratio of -227.63 and a beta of 1.63.

Oscar Health (NYSE:OSCR) last posted its earnings results on Thursday, November 7th. The company reported ($0.22) EPS for the quarter, missing the consensus estimate of ($0.20) by ($0.02). The firm had revenue of $2.42 billion during the quarter, compared to the consensus estimate of $2.33 billion. Oscar Health had a return on equity of 2.79% and a net margin of 0.35%. Oscar Health’s revenue for the quarter was up 68.3% on a year-over-year basis. During the same quarter last year, the company posted ($0.29) EPS. As a group, equities analysts expect that Oscar Health, Inc. will post -0.01 earnings per share for the current year.

Analysts Set New Price Targets

OSCR has been the topic of several research reports. Bank of America cut Oscar Health from a “neutral” rating to an “underperform” rating and cut their price objective for the company from $21.00 to $13.50 in a research note on Wednesday, November 6th. Jefferies Financial Group began coverage on Oscar Health in a research report on Tuesday. They set an “underperform” rating and a $12.00 price target on the stock. Piper Sandler reaffirmed an “overweight” rating and issued a $28.00 price objective on shares of Oscar Health in a report on Tuesday, September 10th. Finally, UBS Group assumed coverage on shares of Oscar Health in a report on Monday, October 7th. They set a “neutral” rating and a $23.00 target price on the stock. Two investment analysts have rated the stock with a sell rating, two have given a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $21.56.

Insider Activity at Oscar Health

In other news, CAO Victoria Baltrus sold 8,078 shares of the firm’s stock in a transaction on Monday, December 2nd. The stock was sold at an average price of $18.08, for a total transaction of $146,050.24. Following the transaction, the chief accounting officer now directly owns 146,036 shares of the company’s stock, valued at approximately $2,640,330.88. This trade represents a 5.24 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Vice Chairman Joshua Kushner acquired 276,040 shares of the business’s stock in a transaction that occurred on Monday, November 11th. The shares were bought at an average price of $13.58 per share, for a total transaction of $3,748,623.20. Following the completion of the purchase, the insider now owns 5,031,262 shares of the company’s stock, valued at approximately $68,324,537.96. This represents a 5.80 % increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last three months, insiders have acquired 1,055,478 shares of company stock worth $14,432,852 and have sold 103,610 shares worth $1,847,519. 25.11% of the stock is owned by insiders.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.